| Name | Title | Contact Details |
|---|
MolecularMD founders Brian Druker (lead clinical investigator for Gleevec, the first molecularly-targeted anticancer agent) and Sheridan G. Snyder (entrepreneur, founder of Genzyme and Upstate Biotechnology) came together with the mission of providing precise, standardized molecular testing for new oncology drugs. The company’s initial accomplishment was in developing and implementing the only standardized assay for quantification of BCR-ABL expression levels, which proved critical to pharmaceutical sponsors in satisfying regulators for approval of the second-generation ABL kinase inhibitors nilotinib (Tasigna, Novartis) and dasatinib (Sprycel, BMS). With that foundational success in supporting pivotal international studies with centralized, high-quality diagnostic services, MolecularMD has become a preferred provider of molecular diagnostics products and services to pharmaceutical and biotech drug developers. Capabilities range from specialty molecular testing services performed in MolecularMD’s centralized CLIA-certified and CAP-accredited laboratory, to development of FDA approved companion diagnostics to support new drug registrations.
We create a community where all are welcome, with a focus on youth development, healthy living, social responsibility, and family strengthening.
Anderson Regional Medical Center is one of the leading companies in Healthcare, Pharmaceuticals, and Biotech industry. Anderson Regional Medical Center is based in Meridian, MS. You can find more information on Anderson Regional Medical Center at www.jarmc.org
Harrington Health is a Wichita, KS-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Mountain States Health Alliance (MSHA), formed in 1998, is the largest health care system in Northeast Tennessee and Southwest Virginia. Our approximately 9,000 team members, associated physicians and volunteers bring loving care to health care every day in each of our facilities.